Literature DB >> 2196745

Restricted expression of measles virus in primary rat astroglial cells.

S Schneider-Schaulies1, U G Liebert, K Baczko, V ter Meulen.   

Abstract

Persistent infection of the central nervous system (CNS) with measles virus (MV) is associated with characteristic restrictions of viral envelope gene expression as documented in subacute sclerosing panencephalitis (SSPE), measles inclusion body encephalitis (MIBE), or subacute measles encephalitis (SAME) in rats. To determine whether these restrictions are the result of a long lasting virus-host cell interaction or primarily based on intrinsic brain cell factors MV gene expression was analyzed in primary rat astroglial cultures. It could be shown that MV infection of these cells led to a defective replication cycle with a reduced synthesis of viral envelope proteins and a steep expression gradient of the monocistronic viral mRNAs similar to the findings in brain tissue of SSPE, MIBE, and SAME. This restriction of MV gene expression has not been observed in cells of nonneural origin. We suggest that this cell-type specific regulation of MV gene expression contributes to early events in the establishment of MV persistent infection in CNS tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196745     DOI: 10.1016/0042-6822(90)90553-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Experimental measles encephalitis in Lewis rats: dissemination of infected neuronal cell subtypes.

Authors:  Ulrike Jehmlich; Jennifer Ritzer; Jens Grosche; Wolfgang Härtig; Uwe G Liebert
Journal:  J Neurovirol       Date:  2013-08-31       Impact factor: 2.643

2.  Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line.

Authors:  Madiha S Ibrahim; Makiko Watanabe; J Alejandro Palacios; Wataru Kamitani; Satoshi Komoto; Takeshi Kobayashi; Keizo Tomonaga; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line.

Authors:  J J Schnorr; S Schneider-Schaulies; A Simon-Jödicke; J Pavlovic; M A Horisberger; V ter Meulen
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Characterization of a glial cell line persistently infected with borna disease virus (BDV): influence of neurotrophic factors on BDV protein and RNA expression.

Authors:  K M Carbone; S A Rubin; A M Sierra-Honigmann; H M Lederman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells.

Authors:  S Schneider-Schaulies; J Schneider-Schaulies; A Schuster; M Bayer; J Pavlovic; V ter Meulen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Canine distemper virus persistence in the nervous system is associated with noncytolytic selective virus spread.

Authors:  A Zurbriggen; H U Graber; A Wagner; M Vandevelde
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

8.  Spontaneous and differentiation-dependent regulation of measles virus gene expression in human glial cells.

Authors:  S Schneider-Schaulies; J Schneider-Schaulies; M Bayer; S Löffler; V ter Meulen
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Studies on canine distemper virus persistence in the central nervous system.

Authors:  C F Müller; R S Fatzer; K Beck; M Vandevelde; A Zurbriggen
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Suppression of measles virus expression by noncytolytic antibody in an immortalized macrophage cell line.

Authors:  M B Goldman; T A O'Bryan; D J Buckthal; L M Tetor; J N Goldman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.